-
Retrospective Single-Center Outcomes After a First Bimatoprost Sustained-Release Implant
16 Dec 2025 11:49 GMT
… fees from Alcon, Aldeyra, Allergan, Bausch and Lomb, Bruder, Sight Sciences, Dompe, Zeiss … , Aurion Biotech, Avelino, Balance Ophthalmics, Bausch and Lomb, Belkin, CorneaGen, Dakota Lions Eye …
-
Living with Glaucoma
16 Dec 2025 09:51 GMT
… pharmaceutical companies, like Allergan and Bausch and Lomb, to teach them how their …
-
Organic chemistry returns
15 Dec 2025 16:50 GMT
… as Miebo (perfluorohexyloctane ophthalmic solution, Bausch + Lomb) and Vevye (cyclosporine ophthalmic solution … speaking and consulting for Allergan, Bausch + Lomb, Sun, Tarsus and Viatris, consulting …
-
<![CDATA[Monitoring MacTel: Why BCVA does not tell the whole story]]>
15 Dec 2025 12:34 GMT
… Pharmaceuticals Inc), Apellis Pharmaceuticals, Astellas, Bausch + Lomb, Clearside Biomedical, EyePoint Pharmaceuticals, Harrow …
-
Massive diorama in storage for decades depicts Rochester circa 1910
15 Dec 2025 10:21 GMT
… Gas & Electric, Bausch + Lomb, and other businesses such … Gas & Electric, Bausch + Lomb and other businesses used to … talk of the park. Bausch + Lomb decontaminated and demolished its … Gas & Electric, Bausch + Lomb, and other businesses such …
-
RBC Capital Keeps Their Buy Rating on DRI Healthcare (DHT.UN)
13 Dec 2025 10:37 GMT
… stocks such as DRI Healthcare, Bausch + Lomb Corporation, and Ligand Pharma.
The …
-
The Art of Combined MIGS
13 Dec 2025 07:54 GMT
… Medical, Sight Sciences, Glaukos and Bausch + Lomb. Dr. Vest is a consultant …
-
<![CDATA[Brent Saunders: Eyeing New Horizons]]>
12 Dec 2025 20:52 GMT
… in between, following Bausch + Lomb’s acquisition by Valeant … on operations and stabilizing Bausch + Lomb’s significant global … or optometrist office.
Bausch + Lomb is planning to advance … CEO of Alnylam Pharmaceuticals. Bausch + Lomb, Saunders says, approached …
-
Fifteen-Month Outcomes of Preservative-Free Latanoprost Cationic Emulsion in Open-Angle Glaucoma and Ocular Hypertension: Phase III Open-Label Extension of a Randomized Trial
12 Dec 2025 16:33 GMT
Introduction
Glaucoma represents a leading cause of irreversible sight loss, affecting approximately 3.6 million people aged 50 years and over worldwide.1 Prevalence increases with age, and quality of life (QoL) diminishes with progressive deterioration of …
-
Multicenter Retrospective Analysis of Intraoperative Aberrometer Measurements and Associated Visual Outcomes with a Monofocal Aspheric Intraocular Lens
12 Dec 2025 16:33 GMT
Introduction
Monofocal intraocular lenses (IOLs) are commonly implanted due to their optimal distance visual acuity (VA) outcomes, minimal photic phenomena,1 and relatively low cost. Introduced in 2018, the Clareon IOL (Alcon Vision LLC, Fort Worth, TX, …
About
© 1995-2025